In AD, tau kinases such as glycogen synthase kinase 3 β (GSK3β), cyclin-dependent kinase 5 (CDK5), and caspase are activated, resulting in tau protein hyperphosphorylation and polymerization into insoluble NFTs. This evidence concerns the gene MAPT and Alzheimer disease.